Diarrhoea is a relatively frequent adverse event, accounting for about 7% o
f all drug adverse effects, More than 700 drugs have been implicated in cau
sing diarrhoea; those most frequently involved are antimicrobials, laxative
s, magnesium-containing antacids, lactose- or sorbitol-containing products,
nonsteroidal antiinflammatory drugs, prostaglandins, colchicine, antineopl
astics, antiarrhythmic drugs and cholinergic agents. Certain new drugs are
likely to induce diarrhoea because of their pharmacodynamic properties; exa
mples include anthraquinone-related agents, alpha-glucosidase inhibitors, l
ipase inhibitors and cholinesterase inhibitors. Antimicrobials are responsi
ble for 25% of drug-induced diarrhoea. The disease spectrum of antimicrobia
l-associated diarrhoea ranges from benign diarrhoea to pseudomembranous col
itis.
Several pathophysiological mechanisms rue involved in drug-induced diarrhoe
a: osmotic diarrhoea, secretory diarrhoea, shortened transit time, exudativ
e diarrhoea and protein-losing enteropathy, and malabsorption or maldigesti
on of fat and carbohydrates. Often 2 or more mechanisms an present simultan
eously.
In clinical practice, 2 major types of diarrhoea are seen: acute diarrhoea,
which usually appears during the first few days of treatment, and chronic
diarrhoea, lasting more than 3 or 4 weeks and which can appear a long time
after the start of drug therapy. Bath can be severe and poorly tolerated,
In a patient presenting with diarrhoea, the medical history is very importa
nt, especially the drug history as it can suggest a diagnosis of drug-induc
ed diarrhoea and thereby avoid multiple diagnostic tests. The clinical exam
ination should cover severity criteria such as fever rectal emission of blo
od and mucus, dehydration and bodyweight loss. Establishing a relationship
between drug consumption and diarrhoea or colitis can he difficult when the
time elapsed between the start of the drug and the onset of symptoms is lo
ng, sometimes up to several months or years.